Aethlon Medical (AEMD) Competitors $1.99 -0.03 (-1.49%) As of 10:11 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEMD vs. GUTS, LUCD, KRMD, LUNG, PDEX, OBIO, INFU, ICAD, ZJYL, and PTHLShould you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Fractyl Health (GUTS), Lucid Diagnostics (LUCD), KORU Medical Systems (KRMD), Pulmonx (LUNG), Pro-Dex (PDEX), Orchestra BioMed (OBIO), InfuSystem (INFU), iCAD (ICAD), Jin Medical International (ZJYL), and Pheton Holdings Ltd Class A Ordinary Shares (PTHL). These companies are all part of the "medical equipment" industry. Aethlon Medical vs. Its Competitors Fractyl Health Lucid Diagnostics KORU Medical Systems Pulmonx Pro-Dex Orchestra BioMed InfuSystem iCAD Jin Medical International Pheton Holdings Ltd Class A Ordinary Shares Fractyl Health (NASDAQ:GUTS) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment, community ranking and dividends. Which has more volatility and risk, GUTS or AEMD? Fractyl Health has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.89, suggesting that its stock price is 89% more volatile than the S&P 500. Which has preferable earnings and valuation, GUTS or AEMD? Aethlon Medical has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$60K1,779.50-$77.09M-$1.85-1.18Aethlon Medical$570K7.02-$12.21M-$12.64-0.16 Do insiders & institutionals believe in GUTS or AEMD? 2.0% of Aethlon Medical shares are owned by institutional investors. 1.2% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to GUTS or AEMD? In the previous week, Aethlon Medical had 3 more articles in the media than Fractyl Health. MarketBeat recorded 4 mentions for Aethlon Medical and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.87 beat Aethlon Medical's score of 0.75 indicating that Fractyl Health is being referred to more favorably in the media. Company Overall Sentiment Fractyl Health Very Positive Aethlon Medical Positive Does the MarketBeat Community believe in GUTS or AEMD? Aethlon Medical received 216 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 50.11% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformFractyl HealthOutperform Votes5100.00% Underperform VotesNo VotesAethlon MedicalOutperform Votes22150.11% Underperform Votes22049.89% Is GUTS or AEMD more profitable? Aethlon Medical has a net margin of 0.00% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets Fractyl Health-64,849.48% N/A -57.21% Aethlon Medical N/A -153.96%-109.13% Do analysts rate GUTS or AEMD? Fractyl Health currently has a consensus target price of $11.00, suggesting a potential upside of 404.59%. Aethlon Medical has a consensus target price of $56.00, suggesting a potential upside of 2,714.07%. Given Aethlon Medical's higher possible upside, analysts plainly believe Aethlon Medical is more favorable than Fractyl Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAethlon Medical beats Fractyl Health on 9 of the 17 factors compared between the two stocks. Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEMD vs. The Competition Export to ExcelMetricAethlon MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.00M$4.39B$5.60B$8.62BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-1.2628.7427.2320.02Price / Sales7.0271.04417.65154.33Price / CashN/A51.0838.2534.64Price / Book0.915.867.124.70Net Income-$12.21M$67.63M$3.23B$247.97M7 Day Performance-26.30%0.85%2.74%2.64%1 Month Performance-39.33%15.89%8.94%6.39%1 Year Performance-52.40%19.04%31.59%13.95% Aethlon Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEMDAethlon Medical3.151 of 5 stars$1.99-1.5%$56.00+2,714.1%-54.1%$4.00M$570K-1.2610Short Interest ↓Gap DownGUTSFractyl Health2.4232 of 5 stars$2.88+44.7%$11.00+281.9%-59.3%$141.05M$60K-0.24102High Trading VolumeLUCDLucid Diagnostics3.5537 of 5 stars$1.30+0.8%$3.55+173.1%+76.6%$139.56M$4.17M-1.1470Positive NewsShort Interest ↓KRMDKORU Medical Systems3.3573 of 5 stars$3.02-1.9%$4.50+49.0%+39.1%$139.35M$35.08M-12.0880News CoverageGap DownLUNGPulmonx3.6496 of 5 stars$3.40+7.3%$11.53+239.0%-49.4%$136.88M$87.47M-2.36250News CoveragePositive NewsPDEXPro-Dex3.1797 of 5 stars$41.25-3.9%$56.00+35.8%+110.3%$134.52M$64.12M20.52140News CoverageOBIOOrchestra BioMed3.0857 of 5 stars$3.34+0.9%$14.20+325.1%-60.2%$127.97M$2.89M-2.074Positive NewsINFUInfuSystem2.4354 of 5 stars$5.95-2.6%$13.00+118.5%N/A$125.05M$137.58M99.18410Negative NewsShort Interest ↑ICADiCAD0.8777 of 5 stars$3.92+0.5%N/A+151.6%$107.69M$19.53M-30.15140Positive NewsShort Interest ↓ZJYLJin Medical InternationalN/A$0.68-11.5%N/A-73.7%$106.61M$23.50M0.00245Positive NewsShort Interest ↓High Trading VolumePTHLPheton Holdings Ltd Class A Ordinary SharesN/A$15.00+11.1%N/AN/A$98.73M$448.20K0.0011High Trading Volume Related Companies and Tools Related Companies GUTS Alternatives LUCD Alternatives KRMD Alternatives LUNG Alternatives PDEX Alternatives OBIO Alternatives INFU Alternatives ICAD Alternatives ZJYL Alternatives PTHL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEMD) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.